Open in QuartrAvailable for iOS and Android
Forte Biosciences Inc
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company focuses on the development of first-in-class oral drugs for cancer, inflammation and fibrosis. Its lead product candidate is a dual inhibitor of chitin synthesis and metalloproteinases (NanoFol14) for the treatment of solid tumors including lung cancer, pancreatic cancer, glioblastoma and other cancers. The company is also developing ubenimex (a CCR5 antagonist), which is used for HIV entry inhibition; and an anti-angiogenesis drug for treating pancreatic cancer and other indications.
Latest events on Quartr
Previous Events for Forte Biosciences Inc
Ticker
FBRX
Country
United States of America
About the company
https://www.fortebiorx.com/home/default.aspx
Investor Relations page
Dig deeper into the fundamentals using Quartr - Investor relations
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
